Diabetes Care Devices Market Size, Share, Analysis by 2028

report image

Diabetes Care Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Glucose Monitoring Devices and Insulin Delivery Devices) and End User (Homecare and Hospitals & Clinics)

Publication Month: May 2022 | Report Code: TIPRE00003753 | No. of Pages: 190 | Category: Medical Device | Status: Published

The diabetes care devices market is expected to grow from US$ 28,942.1 million in 2022 to US$ 42,119.3 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2022 to 2028.

The growth of the diabetes care devices market can be attributed to the rising prevalence of diabetes and increasing support by the government in the US. In the US, diabetes is among the most common and expensive chronic diseases. The highest rate of diabetes is commonly seen in the elder population. However, the rise in the prevalence of diabetes continues across the US, and it is also being seen among the overweight and obese population. According to the International Diabetes Federation (IDF), diabetes affected approximately 32.2 million persons aged 20 to 79 across the US in 2021. Similarly, the total number of diabetics is expected to surge to 34.7 million by 2030 and 36.2 million by 2045. Diabetes among the geriatric population is a growing public health burden. It is a major cause of morbidity and mortality in the aging population and leads to various chronic complications. Moreover, this population is growing exponentially. As per a report of the UN (2019), in 2019, there were ~703 million people aged 65 and older globally. Moreover, according to report of the UN (2019), the global geriatric population is expected to double over the next three decades, reaching 1,549 million by 2050. It is expected to grow significantly in Sub-Saharan Africa, followed by Northern Africa & Western Asia, and Central & Southern Asia. Moreover, governments in Germany are putting their efforts into improving the conditions for people who have diabetes. Along with the government, private companies are also focusing on improving the conditions in the country. According to idf.org, in 2019, an estimated 9.5 million adults in Germany were living with diabetes – putting them at risk of life-threatening complications. 4.5 million of these 9.5 million were undiagnosed. In addition, at least 7.2% of the population in Germany have diabetes, most of them having type 2 diabetes. The number of people with diabetes will increase significantly in the next two decades. 

Strategic Insights

Report Coverage - Diabetes Care Devices Market
Report CoverageDetails
Market Size Value inUS$ 28,942.1 Million in 2022
Market Size Value byUS$ 42,119.3 Million by 2028
Growth rateCAGR of 4.8% from 2022 to 2028
Forecast Period2022-2028
Base Year2022
No. of Pages190
No. of Tables113
No. of Charts & Figures79
Historical data availableYes
Segments coveredType and End User
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Diabetes care devices are the medical devices used to monitor glucose levels in the blood of diabetes patients. Monitoring devices are known as continuous glucose monitoring devices or glucometers. Insulin delivery devices include pumps, syringes, pens, and others. These devices are used by diabetes patients who are unable to produce insulin on their own to inject insulin into their bodies.

Market Insights
Rising Incidence of Diabetes

Diabetes is a deadly chronic disease with no specialized cure. It is primarily caused by the body’s inability to produce or effectively use the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two forms of diabetes diabetes type-I or diabetes insipidus and diabetes type-2 or diabetes mellitus. There is a steady rise in the incidence of diabetes globally. Type 2 diabetes is the most prevalent type of diabetes and has increased with cultural and societal changes. In high-income countries, ~91% of adults have type 2 diabetes. As per the International Diabetes Federation (IDF), diabetes affected ~537 million persons aged 20­–79 in 2021. Similarly, the total number of diabetics is expected to surge to 643 million by 2030 and 783 million by 2045. Diabetes can lead to several complications in various body parts and raise the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are a few major complications associated with diabetes. Hence, patients suffering from this disease require frequent monitoring and external administration of insulin. The growing prevalence of diabetes is fueling the growth of the global diabetes care devices market.

Type - Based Insights

Based on type, the global diabetes care devices market is segmented into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would hold a larger market share in 2022, and the same segment is also estimated to register a higher CAGR during the forecast period.

Global Diabetes Care Devices Market, by Type – 2022–2028

Global Diabetes Care Devices Market, by Type – 2022–2028

Get more information on this report :

The diabetes care devices market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio globally and meet the growing demand. The developments by the companies in the global diabetes care devices market have been characterized as organic and inorganic developments. Various companies are focusing on organic strategies such as product launch and expansion. Inorganic growth strategies witnessed in the diabetes care devices market were partnerships and collaborations. These growth strategies have aided the market players in expanding their businesses and enhancing their geographic presence. Additionally, growth strategies such as acquisitions and partnerships helped strengthen their customer base and increase the product portfolio. The companies have maximized their growth with several inorganic strategies to enhance the diabetes care devices market value and their position in the diabetes care devices market. Organic developments hold 85.19% of the total strategic developments in the global diabetes care devices market, whereas inorganic strategies account for 14.81% of the growth of the companies.

The diabetes care devices market has been segmented as follows:

The global diabetes care devices market is segmented based on type and end user. Based on type, the global diabetes care devices market is segmented into glucose monitoring devices and insulin delivery devices. The global diabetes care devices market, based on end user, is bifurcated into homecare and hospitals & clinics.

Company Profiles

  • BD
  • Novo Nordisk A/S
  • B. Braun Melsungen AG
  • Medtronic
  • Tandem Diabetes Care Inc.
  • Insulet Corporation
  • Eli Lilly and Company
  • DEXCOM, INC.
  • Terumo Corporation
  • F. HOFFMANN-LA ROCHE LTD.

Frequently Asked Questions

The diabetes care devices are the medical devices used to monitor the glucose levels in the blood of diabetic patients. The monitoring devices are known as continuous glucose monitoring devices or glucometers. Insulin delivery devices are used to deliver insulin in the body, these devices are used by the diabetes patients who are unable to produce insulin by their own. These devices include pens, pumps, syringes and others.
The factors that are driving the growth of the market are rising incidence of diabetes and growing geriatric population.
The glucose monitoring devices segment is expected to be the leading type segment in the diabetes care devices market in 2021.
The homecare segment are expected to be the leading end user segment in the diabetes care devices market in 2021.
The global diabetes care devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The largest market for diabetes care devices is held by the North American region. The United States held the largest market for diabetes care devices. The Asia-Pacific region is expected to be the fastest-growing region during the forecast period.
The diabetes care devices market majorly consists of the players such as BD; Novo Nordisk A/S; B. Braun Melsungen AG; Medtronic; Tandem Diabetes Care Inc.; Insulet Corporation; Eli Lilly and Company; DEXCOM, INC.; Terumo Corporation; F. HOFFMANN-LA ROCHE LTD.; among others.

The List of Companies - Diabetes Care Devices Market

  1. BD
  2. Novo Nordisk A/S
  3. B. Braun Melsungen AG
  4. Medtronic
  5. Tandem Diabetes Care Inc.
  6. Insulet Corporation
  7. Eli Lilly and Company
  8. DEXCOM, INC.
  9. Terumo Corporation
  10. F. HOFFMANN-LA ROCHE LTD.
  • Provide strong and enough study of the Diabetes Care Devices market that help in understanding the market.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global Diabetes Care Devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Diabetes Care Devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00003753
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount